Hemolytic-uremic syndrome screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{HUS}} | {{HUS}} | ||
{{CMG}}; {{AE}} {{AHS}} | {{CMG}}; {{AE}} {{S.G.}}, {{AHS}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend screening for Hemolytic- | There is insufficient evidence to recommend screening for [[Hemolytic-uremic syndrome|hemolytic uremic syndrome]] ([[Hemolytic-uremic syndrome|HUS]]). | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for HUS. | There is insufficient evidence to recommend routine screening for [[Hemolytic-uremic syndrome|HUS]]. | ||
==References== | ==References== | ||
Latest revision as of 16:45, 21 August 2018
|
Hemolytic-uremic syndrome Microchapters |
|
Differentiating Hemolytic-uremic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hemolytic-uremic syndrome screening On the Web |
|
American Roentgen Ray Society Images of Hemolytic-uremic syndrome screening |
|
Risk calculators and risk factors for Hemolytic-uremic syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2], Anila Hussain, MD [3]
Overview
There is insufficient evidence to recommend screening for hemolytic uremic syndrome (HUS).
Screening
There is insufficient evidence to recommend routine screening for HUS.